COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension ...
| ID | 39373511000001104 |
|---|---|
| Concept | Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials |
| Name | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials |
| Abbreviated name | COVID-19 Vaccine Valneva 0.5ml inj multidose vials |
| Description | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd) |
| Date of name applicability | 16 Mar 2021 |
| Previous Name | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials |
| Supplier | Valneva UK Ltd |
| Licensed as | Medicines - MHRA/EMA |
| Previously licensed as | None |
| License change reason | Licence Granted |
| Date of change of licensing authority | 21 Nov 2022 |
| EMA (European Medicines Agency) Monitoring | 1 |
| Restrictions on availability | Restricted Availability |
| Licensed route | Intramuscular |